Sophie Glatt

1.1k total citations
14 papers, 858 citations indexed

About

Sophie Glatt is a scholar working on Immunology, Dermatology and Molecular Biology. According to data from OpenAlex, Sophie Glatt has authored 14 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Dermatology and 3 papers in Molecular Biology. Recurrent topics in Sophie Glatt's work include Psoriasis: Treatment and Pathogenesis (4 papers), Dermatology and Skin Diseases (3 papers) and TGF-β signaling in diseases (3 papers). Sophie Glatt is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (4 papers), Dermatology and Skin Diseases (3 papers) and TGF-β signaling in diseases (3 papers). Sophie Glatt collaborates with scholars based in United Kingdom, United States and Belgium. Sophie Glatt's co-authors include Stevan Shaw, Foteini Strimenopoulou, Lucian Ionescu, Dominique Baeten, Pavan Vajjah, Jonathan M. Yingling, L. Buéno, Iñaki F. Trocóniz, Celine Pitou and Dinesh P. de Alwis and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and Annals of the Rheumatic Diseases.

In The Last Decade

Sophie Glatt

14 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Glatt United Kingdom 10 365 243 189 177 142 14 858
Lori Capone Switzerland 9 399 1.1× 131 0.5× 466 2.5× 162 0.9× 179 1.3× 13 1.0k
Csilla Sipeky Hungary 18 187 0.5× 29 0.1× 183 1.0× 89 0.5× 141 1.0× 39 723
Jonghyeon Kim United States 17 141 0.4× 33 0.1× 208 1.1× 224 1.3× 95 0.7× 28 1.4k
Lawrence W. Argenbright United States 11 224 0.6× 29 0.1× 123 0.7× 29 0.2× 59 0.4× 14 628
Helen E. McGrath United States 19 159 0.4× 33 0.1× 529 2.8× 20 0.1× 292 2.1× 33 1.2k
Basharut A. Syed United Kingdom 15 88 0.2× 22 0.1× 250 1.3× 73 0.4× 77 0.5× 24 678
Jill Skepner United States 7 390 1.1× 46 0.2× 212 1.1× 44 0.2× 164 1.2× 7 690
Jie Lei China 18 311 0.9× 50 0.2× 474 2.5× 42 0.2× 203 1.4× 53 948
G. J. Romeijn Netherlands 9 246 0.7× 15 0.1× 674 3.6× 45 0.3× 25 0.2× 11 841
Xiaoying Sun China 20 376 1.0× 48 0.2× 663 3.5× 36 0.2× 787 5.5× 50 1.6k

Countries citing papers authored by Sophie Glatt

Since Specialization
Citations

This map shows the geographic impact of Sophie Glatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Glatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Glatt more than expected).

Fields of papers citing papers by Sophie Glatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Glatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Glatt. The network helps show where Sophie Glatt may publish in the future.

Co-authorship network of co-authors of Sophie Glatt

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Glatt. A scholar is included among the top collaborators of Sophie Glatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Glatt. Sophie Glatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Glatt, Sophie, Gregor B. E. Jemec, Seth Forman, et al.. (2021). Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa. JAMA Dermatology. 157(11). 1279–1279. 112 indexed citations
3.
4.
Glatt, Sophie, Peter C. Taylor, Iain B. McInnes, et al.. (2019). Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study. Annals of the Rheumatic Diseases. 78(8). 1033–1040. 49 indexed citations
5.
6.
Gosset, J, Kevin Beaumont, Wendy J. Winchester, et al.. (2017). A cross-species translational pharmacokinetic-pharmacodynamic evaluation of core body temperature reduction by the TRPM8 blocker PF-05105679. European Journal of Pharmaceutical Sciences. 109. S161–S167. 10 indexed citations
7.
Glatt, Sophie, Eric Helmer, Birgit Haier, et al.. (2016). First‐in‐human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL‐17A and IL‐17F, in mild psoriasis. British Journal of Clinical Pharmacology. 83(5). 991–1001. 114 indexed citations
8.
9.
Winchester, Wendy J., Sophie Glatt, Kelly Conlon, et al.. (2014). Inhibition of TRPM8 Channels Reduces Pain in the Cold Pressor Test in Humans. Journal of Pharmacology and Experimental Therapeutics. 351(2). 259–269. 72 indexed citations
10.
Hatterer, Eric, Bruno Daubeuf, Laura Cons, et al.. (2013). Characterization of a surrogate murine antibody to model anti-human CD3 therapies. mAbs. 5(4). 555–564. 7 indexed citations
11.
Baselga, José, Sophie Glatt, Ann Cleverly, et al.. (2008). First human dose escalation study in patients with metastatic malignancies to determine safety and pharmacokinetics of LY2157299, a small molecule inhibitor of the transforming growth factor-beta receptor I kinase. Journal of Clinical Oncology. 26(15_suppl). 14554–14554. 29 indexed citations
12.
Buéno, L., Dinesh P. de Alwis, Celine Pitou, et al.. (2007). Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice. European Journal of Cancer. 44(1). 142–150. 174 indexed citations
13.
Gueorguieva, Ivelina, Kayode Ogungbenro, Gordon Graham, Sophie Glatt, & Leon Aarons. (2007). A program for individual and population optimal design for univariate and multivariate response pharmacokinetic–pharmacodynamic models. Computer Methods and Programs in Biomedicine. 86(1). 51–61. 45 indexed citations
14.
Glatt, Sophie, et al.. (2005). Population Pharmacokinetics of Onercept in Healthy Subjects. Clinical Pharmacokinetics. 44(12). 1295–1304. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lori Capone Breakdown of academic impact, for papers by Csilla Sipeky Breakdown of academic impact, for papers by Jonghyeon Kim Breakdown of academic impact, for papers by Lawrence W. Argenbright Breakdown of academic impact, for papers by Helen E. McGrath Breakdown of academic impact, for papers by Basharut A. Syed Breakdown of academic impact, for papers by Jill Skepner Breakdown of academic impact, for papers by Jie Lei Breakdown of academic impact, for papers by G. J. Romeijn Breakdown of academic impact, for papers by Xiaoying Sun
Rankless by CCL
2026